GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » Other Long Term Assets

Halberd (Halberd) Other Long Term Assets : $-0.00 Mil (As of Jul. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Halberd Other Long Term Assets?

Halberd's other long-term assets for the quarter that ended in Jul. 2023 was $-0.00 Mil.

Halberd's quarterly other long-term assets declined from Jul. 2008 ($0.02 Mil) to Jul. 2022 ($-0.00 Mil) but then stayed the same from Jul. 2022 ($-0.00 Mil) to Jul. 2023 ($-0.00 Mil).

Halberd's annual other long-term assets declined from Jul. 2008 ($0.02 Mil) to Jul. 2022 ($-0.00 Mil) and declined from Jul. 2022 ($-0.00 Mil) to Jul. 2023 ($-0.00 Mil).


Halberd Other Long Term Assets Historical Data

The historical data trend for Halberd's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd Other Long Term Assets Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
Other Long Term Assets
0.02 - -

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
Other Long Term Assets 0.02 - -

Halberd Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Halberd (Halberd) Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.
Executives
John Christopher Maddox director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO 10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist director, 10 percent owner, officer: CEO, Secretary and Director 24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr. director 50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas director 280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236